Inhibition of Mir-21-5p Affects the Expression of LNCRNA X-Inactive Specific Transcript and Induces Apoptosis in MCF-7 Breast Cancer Cells

Overview

Journal Iran J Public Health

Date 2024 Jun 26

PMID 38919297

Authors

Samaneh Nejaddehghan

Seyed Jalal Zargar

Mana Oloomi

Kazem Baesi

Morteza Kouhsar

Affiliations

Soon will be listed here.

Abstract

Background: We aimed to investigate miR-21-5p inhibition effect on lncRNA-XIST expression and apoptosis status of MCF-7 cells.

Methods: The MCF-7 cells were cultured and transfected by the anti-miR-21-5p oligonucleotide and expression of miR-21-5p, lncRNA-XIST, apoptosis-associated genes ( and ) and one miR-21-5p-unrelated lncRNA (BC200) was assessed by RT-qPCR. Furthermore, cell viability checked by MTT assay and apoptosis and cell cycle in transfected cells were detected by flow cytometry. Also, bioinformatics analysis on the transcriptome data confirmed that the lncRNA XIST might have a critical role in breast cancer (BC) cell apoptosis through ceRNAs mechanism and possible regulatory interactions with miR-21-5p.

Results: Expression of miR-21-5p and lncRNA-XIST was significantly down- and up-regulated respectively (<0.05). However, there was no significant change in lncRNA-BC200 expression. Also, the expression of and upraised significantly (<0.05). In transfected cells, MTT and flow cytometry assays reported a highly significant decrease and increase in viability and apoptosis respectively.

Conclusion: Inhibition of miR-21-5p resulted in significant upregulation of lncRNA-XIST and apoptosis-associated genes and , which led to the induction of apoptosis in MCF-7 cells. Therefore, more investigations may provide a valuable target for studies on molecular therapies for BC.

References

Azadeh M, Salehzadeh A, Ghaedi K, Sasani S . NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysis. Genes Environ. 2022; 44(1):16. PMC: 9112444. DOI: 10.1186/s41021-022-00244-3. View

Parfenyev S, Singh A, Fedorova O, Daks A, Kulshreshtha R, Barlev N . Interplay between p53 and non-coding RNAs in the regulation of EMT in breast cancer. Cell Death Dis. 2021; 12(1):17. PMC: 7791039. DOI: 10.1038/s41419-020-03327-7. View

Karagkouni D, Paraskevopoulou M, Chatzopoulos S, Vlachos I, Tastsoglou S, Kanellos I . DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Res. 2017; 46(D1):D239-D245. PMC: 5753203. DOI: 10.1093/nar/gkx1141. View

Esmatabadi M, Farhangi B, Montazeri M, Monfared H, Nakhaei Sistani R, Sadeghizadeh M . Up-regulation of miR-21 decreases chemotherapeutic effect of dendrosomal curcumin in breast cancer cells. Iran J Basic Med Sci. 2017; 20(4):350-359. PMC: 5425916. DOI: 10.22038/IJBMS.2017.8574. View

Ma Y, Yu L, Yan W, Qiu L, Zhang J, Jia X . lncRNA GAS5 Sensitizes Breast Cancer Cells to Ionizing Radiation by Inhibiting DNA Repair. Biomed Res Int. 2022; 2022:1987519. PMC: 8766191. DOI: 10.1155/2022/1987519. View

Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z . MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res. 2010; 1352:255-64. DOI: 10.1016/j.brainres.2010.07.009. View

Si M, Zhu S, Wu H, Lu Z, Wu F, Mo Y . miR-21-mediated tumor growth. Oncogene. 2006; 26(19):2799-803. DOI: 10.1038/sj.onc.1210083. View

Huang Y, Chang C, Lee S, Jou Y, Shih H . Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression. Oncotarget. 2016; 7(28):43256-43266. PMC: 5190021. DOI: 10.18632/oncotarget.9673. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

10.

Zhang R, Xia T . Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis. Int J Oncol. 2017; 51(5):1460-1470. PMC: 5643066. DOI: 10.3892/ijo.2017.4127. View

11.

Frankel L, Christoffersen N, Jacobsen A, Lindow M, Krogh A, Lund A . Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 2007; 283(2):1026-33. DOI: 10.1074/jbc.M707224200. View

12.

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View

13.

Li J, Huang H, Sun L, Yang M, Pan C, Chen W . MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res. 2009; 15(12):3998-4008. DOI: 10.1158/1078-0432.CCR-08-3053. View

14.

Becker Buscaglia L, Li Y . Apoptosis and the target genes of microRNA-21. Chin J Cancer. 2011; 30(6):371-80. PMC: 3319771. DOI: 10.5732/cjc.011.10132. View

15.

Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999; 28(1):27-30. PMC: 102409. DOI: 10.1093/nar/28.1.27. View

16.

Ma X, Liu C, Xu X, Liu L, Gao C, Zhuang J . Biomarker expression analysis in different age groups revealed age was a risk factor for breast cancer. J Cell Physiol. 2019; 235(5):4268-4278. DOI: 10.1002/jcp.29304. View

17.

Jiang B, Zhu H, Feng W, Wan Z, Qi X, He R . Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer. Dis Markers. 2022; 2022:9004830. PMC: 9605827. DOI: 10.1155/2022/9004830. View

18.

Zhao Z, Bai J, Wu A, Wang Y, Zhang J, Wang Z . Co-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-Seq data. Database (Oxford). 2015; 2015. PMC: 4565967. DOI: 10.1093/database/bav082. View

19.

Kouhsar M, Azimzadeh Jamalkandi S, Moeini A, Masoudi-Nejad A . Detection of novel biomarkers for early detection of Non-Muscle-Invasive Bladder Cancer using Competing Endogenous RNA network analysis. Sci Rep. 2019; 9(1):8434. PMC: 6557814. DOI: 10.1038/s41598-019-44944-3. View

20.

Iacoangeli A, Lin Y, Morley E, Muslimov I, Bianchi R, Reilly J . BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis. 2004; 25(11):2125-33. DOI: 10.1093/carcin/bgh228. View